Source: EIN Presswire

Press Release: Hyasynth Bio : Hyasynth announces production of >20 rare cannabinoids by fermentation & US patent grant on novel biosynthesis pathway

MONTREAL, QUEBEC, CANADA, May 26, 2021 /⁨EINPresswire.com⁩/ -- Hyasynth, a sustainable biotechnology company specializing in fermentation-produced cannabinoid ingredients, today announced an update on its biosynthesis process and patent portfolio. On April ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kevin Chen's photo - Co-Founder & CEO of Hyasynth Bio

Co-Founder & CEO

Kevin Chen

CEO Approval Rating

76/100

Read more